2021-11-16-世界卫生组织-Cervical_cancer_Belize_2021_country_profile_1页_65kb

Belize Cervical Cancer Profile Summary

Morbidity and Mortality

• Crude cervical cancer incidence (2020): Data not specified, but age-standardized incidence is 19.1 per 100,000 women.
• Cumulative risk of cervical cancer (ages 0-74, 2020): 17 per 100,000.
• Deaths (2019): 720.
• Mortality-to-incidence ratio (2020): 0.74.
• Population-based cancer registry exists (2021).

Primary Prevention

• HPV vaccination program: Introduced in 2016, covers 11% of national target population (9-14-year-old girls) by 2020. HPV included in national program; target cohort is girls aged 9-14.
• Coverage: 2% of target cohort received final dose in 2020.
• Risk factors: Tobacco use prevalence among women aged 15+ is 1.8% (data from 2020, risk of all tobacco assumed); condom use and HIV incidence data not available.

Secondary Prevention (Screening)

• National screening program for cervical cancer: Exits no (2021); primary screening test not specified.
• Target age range: Not defined, but data shows screening up to 49 years.
• Ever screened percentage: 47% of women aged over a certain range have been screened.
• Performance: 62% of women aged 30-49 years identified with high-performance test by 35 years old; screening guidelines for early detection at primary health care level not defined.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist (2021).
• Data on radiotherapy, brachytherapy, and staff numbers inconsistent or missing.
• Cancer surgery, chemotherapy, and radiation oncology personnel not fully specified.
• Palliative care available for NCDs in public health system.
• Opioid consumption data per capita not provided.

WHO Elimination Strategy Targets (2030)

• Not detailed, but mentions overall population and related indicators.
• WHO cervical cancer country profiles referenced.